United States Heavy Metal Poisoning Drugs Market Report 2017

December 2017 | 101 pages | ID: UA45AB9E524EN
QYResearch

Abstracts

In this report, the United States Heavy Metal Poisoning Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Heavy Metal Poisoning Drugs in these regions, from 2012 to 2022 (forecast).

United States Heavy Metal Poisoning Drugs market competition by top manufacturers/players, with Heavy Metal Poisoning Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alnylam Pharmaceuticals Inc
• La Jolla Pharmaceutical Company
• Medesis Pharma SA
• Novartis AG
• PDX Pharmaceuticals LLC

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ALN-TMP
• Deferasirox
• Deferoxamine Mesylate
• Emeramide
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Arsenic Toxicity
• Chromium Toxicity
• Copper Toxicity
• Lead Toxicity
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Heavy Metal Poisoning Drugs Market Report 2017

1 HEAVY METAL POISONING DRUGS OVERVIEW

1.1 Product Overview and Scope of Heavy Metal Poisoning Drugs
1.2 Classification of Heavy Metal Poisoning Drugs by Product Category
  1.2.1 United States Heavy Metal Poisoning Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Heavy Metal Poisoning Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 ALN-TMP
  1.2.4 Deferasirox
  1.2.5 Deferoxamine Mesylate
  1.2.6 Emeramide
  1.2.7 Others
1.3 United States Heavy Metal Poisoning Drugs Market by Application/End Users
  1.3.1 United States Heavy Metal Poisoning Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Arsenic Toxicity
  1.3.3 Chromium Toxicity
  1.3.4 Copper Toxicity
  1.3.5 Lead Toxicity
  1.3.6 Others
1.4 United States Heavy Metal Poisoning Drugs Market by Region
  1.4.1 United States Heavy Metal Poisoning Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
  1.4.5 New England Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
  1.4.6 The South Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Heavy Metal Poisoning Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Heavy Metal Poisoning Drugs (2012-2022)
  1.5.1 United States Heavy Metal Poisoning Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Heavy Metal Poisoning Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEAVY METAL POISONING DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Heavy Metal Poisoning Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Heavy Metal Poisoning Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Heavy Metal Poisoning Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Heavy Metal Poisoning Drugs Market Competitive Situation and Trends
  2.4.1 United States Heavy Metal Poisoning Drugs Market Concentration Rate
  2.4.2 United States Heavy Metal Poisoning Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Heavy Metal Poisoning Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEAVY METAL POISONING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Heavy Metal Poisoning Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Heavy Metal Poisoning Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Heavy Metal Poisoning Drugs Price by Region (2012-2017)

4 UNITED STATES HEAVY METAL POISONING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Heavy Metal Poisoning Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Heavy Metal Poisoning Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Heavy Metal Poisoning Drugs Price by Type (2012-2017)
4.4 United States Heavy Metal Poisoning Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEAVY METAL POISONING DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Heavy Metal Poisoning Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Heavy Metal Poisoning Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEAVY METAL POISONING DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alnylam Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Heavy Metal Poisoning Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 La Jolla Pharmaceutical Company
  6.2.2 Heavy Metal Poisoning Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Medesis Pharma SA
  6.3.2 Heavy Metal Poisoning Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Medesis Pharma SA Heavy Metal Poisoning Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis AG
  6.4.2 Heavy Metal Poisoning Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis AG Heavy Metal Poisoning Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 PDX Pharmaceuticals LLC
  6.5.2 Heavy Metal Poisoning Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 HEAVY METAL POISONING DRUGS MANUFACTURING COST ANALYSIS

7.1 Heavy Metal Poisoning Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Heavy Metal Poisoning Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Heavy Metal Poisoning Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Heavy Metal Poisoning Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEAVY METAL POISONING DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Heavy Metal Poisoning Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Heavy Metal Poisoning Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Heavy Metal Poisoning Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Heavy Metal Poisoning Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Heavy Metal Poisoning Drugs
Figure United States Heavy Metal Poisoning Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure ALN-TMP Product Picture
Figure Deferasirox Product Picture
Figure Deferoxamine Mesylate Product Picture
Figure Emeramide Product Picture
Figure Others Product Picture
Figure United States Heavy Metal Poisoning Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Heavy Metal Poisoning Drugs by Application in 2016
Figure Arsenic Toxicity Examples
Table Key Downstream Customer in Arsenic Toxicity
Figure Chromium Toxicity Examples
Table Key Downstream Customer in Chromium Toxicity
Figure Copper Toxicity Examples
Table Key Downstream Customer in Copper Toxicity
Figure Lead Toxicity Examples
Table Key Downstream Customer in Lead Toxicity
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Heavy Metal Poisoning Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Heavy Metal Poisoning Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Heavy Metal Poisoning Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Heavy Metal Poisoning Drugs Sales Share by Players/Suppliers
Figure 2017 United States Heavy Metal Poisoning Drugs Sales Share by Players/Suppliers
Figure United States Heavy Metal Poisoning Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Heavy Metal Poisoning Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Heavy Metal Poisoning Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Heavy Metal Poisoning Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Heavy Metal Poisoning Drugs Revenue Share by Players/Suppliers
Table United States Market Heavy Metal Poisoning Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Heavy Metal Poisoning Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Heavy Metal Poisoning Drugs Market Share of Top 3 Players/Suppliers
Figure United States Heavy Metal Poisoning Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Heavy Metal Poisoning Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Heavy Metal Poisoning Drugs Product Category
Table United States Heavy Metal Poisoning Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales Share by Region (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Share by Region (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Market Share by Region in 2016
Table United States Heavy Metal Poisoning Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Heavy Metal Poisoning Drugs Revenue Share by Region (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Revenue Market Share by Region (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Revenue Market Share by Region in 2016
Table United States Heavy Metal Poisoning Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales Share by Type (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Share by Type (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Market Share by Type in 2016
Table United States Heavy Metal Poisoning Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Heavy Metal Poisoning Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Heavy Metal Poisoning Drugs by Type (2012-2017)
Figure Revenue Market Share of Heavy Metal Poisoning Drugs by Type in 2016
Table United States Heavy Metal Poisoning Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Growth Rate by Type (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Heavy Metal Poisoning Drugs Sales Market Share by Application (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Market Share by Application (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Market Share by Application in 2016
Table United States Heavy Metal Poisoning Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Heavy Metal Poisoning Drugs Sales Growth Rate by Application (2012-2017)
Table Alnylam Pharmaceuticals Inc Basic Information List
Table Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Sales Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Sales Market Share in United States (2012-2017)
Figure Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Revenue Market Share in United States (2012-2017)
Table La Jolla Pharmaceutical Company Basic Information List
Table La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Sales Growth Rate (2012-2017)
Figure La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Sales Market Share in United States (2012-2017)
Figure La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Revenue Market Share in United States (2012-2017)
Table Medesis Pharma SA Basic Information List
Table Medesis Pharma SA Heavy Metal Poisoning Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Medesis Pharma SA Heavy Metal Poisoning Drugs Sales Growth Rate (2012-2017)
Figure Medesis Pharma SA Heavy Metal Poisoning Drugs Sales Market Share in United States (2012-2017)
Figure Medesis Pharma SA Heavy Metal Poisoning Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Heavy Metal Poisoning Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Heavy Metal Poisoning Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Heavy Metal Poisoning Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Heavy Metal Poisoning Drugs Revenue Market Share in United States (2012-2017)
Table PDX Pharmaceuticals LLC Basic Information List
Table PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Sales Growth Rate (2012-2017)
Figure PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Sales Market Share in United States (2012-2017)
Figure PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Heavy Metal Poisoning Drugs
Figure Manufacturing Process Analysis of Heavy Metal Poisoning Drugs
Figure Heavy Metal Poisoning Drugs Industrial Chain Analysis
Table Raw Materials Sources of Heavy Metal Poisoning Drugs Major Players/Suppliers in 2016
Table Major Buyers of Heavy Metal Poisoning Drugs
Table Distributors/Traders List
Figure United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Heavy Metal Poisoning Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Heavy Metal Poisoning Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Heavy Metal Poisoning Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources